Table 3

Spearman's rank correlation coefficient of PVFBWin comparison with measuresa
Comparison of PVFBWwith: n D0 (95% CI) D30 (95% CI) D90 (95% CI) Difference D0D30 (95% CI) Difference D30D90 (95% CI)
Primary endpoints
CSOM 23 -.03 (−.64, .32) .10 (−.38, .57) -.37 (−.74, .12) .13 (−.44, .66) -.71 (−.91, -.34)
EDA 23 -.23 (−.61, .24) .10 (−.44, .60) .16 (−.36, .62) -.12 (−.60, .43) .31 (−.23, .69)
Exploratory endpoints
MA 7 -.46 (−1.0, .77) .10 (−1.0, 1.0) .45 (−.68, 1.0) -.04 (−.94, 1.0) .14 (−1.0, 0.80)
Ctg(1) 20 -.20 (−.65, .42) -.29 (−.66, .21) -.13 (−.58, .40) -.03 (−.67, .74) -.64 (−.87, -.15)
Ctg(2) 10 .01 (−.77, .78) .00 (−.77, .79) -.75 (−1.0, 0.00) -.03 (−.81, .74) -.52 (−.90, .45)
Ctg(3) 9 .56 (−.72, 1.0) .54 (−.31, 1.0) .52 (−.81, 1.0) .00 (−.91, .92) -.99 (−1.0, -.87)
Ctg(4) 8 .20 (−.44, .94) .09 (−.91, 1.0) .07 (−.91, 1.0) .20 (−.94, 1.0) -.66 (−1.0, .71)

PVFBW: peak vertical ground reaction force adjusted for body weight change.

aCSOM: client-specific outcome measures; EDA: electrodermal activity; MA: motor activity; Ctg(1): Reduced mobility; Ctg(2): Reduced mobility after exercise; Ctg(3): Reduced ability to change posture; Ctg(4): Reduced ability to change posture after rest or in the morning.

Descriptive data are represented as Spearman's rank correlation coefficient at day(D)0, D30, D90, difference between D0 and D30 (D0D30), and difference between D30 and D90 (D30D90). 95% CI: 95% confidence interval from bootstrap method of sample of n dogs (1000 samples randomly selected with replacement). NA: not available.

Rialland et al.

Rialland et al. BMC Veterinary Research 2012 8:162   doi:10.1186/1746-6148-8-162

Open Data